Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Promyelocytic, Acute 10 Neuroblastoma 4 Lung Neoplasms 4 Leukemia, Myeloid, Acute 4 Leukemia 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 2 Thrombocytopenia 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Melanoma 2 Colorectal Neoplasms 2 Wilms Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, B-Cell 1 Lymphoma 1 Leiomyosarcoma 1 Kidney Neoplasms 1 HER2 Negative Breast Cancer 1 Glioma 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × HER2 Negative Breast Cancer × Tretinoin × Clear all

NCT06731140 2025-11-17

Resilire

Fudan University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡